Search results for: 'Identity and Access Management, 2022'
- Related search terms
- 2022 Annual Update of Global LED Lighting Market
- 2022 Prediction of Global Electric Vehicle Market Outlook
- 2022 us evtol power service market
- 2022 us editing power service market
- 2022 us plan distribution service market
-
23 Aug 2010  |  North America  |  Market Research
Vital Signs - Biomarkers for Improved and Accelerated Sepsis Treatment: Enabling Clinicians to Definitively Diagnose the Disease, Identify the Causative Agent, and Determine the Appropriate Type and Dosage of Antibiotic
This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...
$1,500.00
Special Price $1,125.00 save 25 %